Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA

NCT05354765 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Immune System or Toxicities Suspected

Interventions

OTHER: blood sample
OTHER: blood sample

Sponsor

Institut Curie